Literature DB >> 20411383

Three pathways for human kidney stone formation.

Fredric L Coe1, Andrew P Evan, Elaine M Worcester, James E Lingeman.   

Abstract

No single theory of pathogenesis can properly account for human kidney stones, they are too various and their formation is too complex for simple understanding. Using human tissue biopsies, intraoperative imaging and such physiology data from ten different stone forming groups, we have identified at least three pathways that lead to stones. The first pathway is overgrowth on interstitial apatite plaque as seen in idiopathic calcium oxalate stone formers, as well as stone formers with primary hyperparathyroidism, ileostomy, and small bowel resection, and in brushite stone formers. In the second pathway, there are crystal deposits in renal tubules that were seen in all stone forming groups except the idiopathic calcium oxalate stone formers. The third pathway is free solution crystallization. Clear examples of this pathway are those patient groups with cystinuria or hyperoxaluria associated with bypass surgery for obesity. Although the final products may be very similar, the ways of creation are so different that in attempting to create animal and cell models of the processes one needs to be careful that the details of the human condition are included.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20411383      PMCID: PMC3169174          DOI: 10.1007/s00240-010-0271-8

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  22 in total

1.  Urine calcium and volume predict coverage of renal papilla by Randall's plaque.

Authors:  Ramsay L Kuo; James E Lingeman; Andrew P Evan; Ryan F Paterson; Joan H Parks; Sharon B Bledsoe; Larry C Munch; Fredric L Coe
Journal:  Kidney Int       Date:  2003-12       Impact factor: 10.612

2.  Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization.

Authors:  Andrew P Evan; Fredric L Coe; Susan R Rittling; Sharon M Bledsoe; Youzhi Shao; James E Lingeman; Elaine M Worcester
Journal:  Kidney Int       Date:  2005-07       Impact factor: 10.612

3.  Endoscopic evidence of calculus attachment to Randall's plaque.

Authors:  Brian R Matlaga; James C Williams; Samuel C Kim; Ramsay L Kuo; Andrew P Evan; Sharon B Bledsoe; Fredric L Coe; Elaine M Worcester; Larry C Munch; James E Lingeman
Journal:  J Urol       Date:  2006-05       Impact factor: 7.450

4.  Urine stone risk factors in nephrolithiasis patients with and without bowel disease.

Authors:  Joan H Parks; Elaine M Worcester; R Corey O'Connor; Fredric L Coe
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

5.  Crystal-associated nephropathy in patients with brushite nephrolithiasis.

Authors:  Andrew P Evan; James E Lingeman; Fredric L Coe; Youzhi Shao; Joan H Parks; Sharon B Bledsoe; Carrie L Phillips; Stephen Bonsib; Elaine M Worcester; Andre J Sommer; Sam C Kim; William W Tinmouth; Marc Grynpas
Journal:  Kidney Int       Date:  2005-02       Impact factor: 10.612

6.  Renal crystal deposits and histopathology in patients with cystine stones.

Authors:  A P Evan; F L Coe; J E Lingeman; Y Shao; B R Matlaga; S C Kim; S B Bledsoe; A J Sommer; M Grynpas; C L Phillips; E M Worcester
Journal:  Kidney Int       Date:  2006-05-17       Impact factor: 10.612

Review 7.  Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis.

Authors:  A Evan; J Lingeman; F L Coe; E Worcester
Journal:  Kidney Int       Date:  2006-04       Impact factor: 10.612

8.  Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones.

Authors:  Joan H Parks; Elaine M Worcester; Fredric L Coe; Andrew P Evan; James E Lingeman
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

9.  Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy.

Authors:  Andrew P Evan; James E Lingeman; Fredric L Coe; Sharon B Bledsoe; Andre J Sommer; James C Williams; Amy E Krambeck; Elaine M Worcester
Journal:  Kidney Int       Date:  2009-08-26       Impact factor: 10.612

10.  The spectrum of metabolic abnormalities in patients with cystine nephrolithiasis.

Authors:  K Sakhaee; J R Poindexter; C Y Pak
Journal:  J Urol       Date:  1989-04       Impact factor: 7.450

View more
  78 in total

1.  The effect of intracrystalline and surface-bound osteopontin on the degradation and dissolution of calcium oxalate dihydrate crystals in MDCKII cells.

Authors:  Lauren A Thurgood; Esben S Sørensen; Rosemary L Ryall
Journal:  Urol Res       Date:  2011-09-20

2.  Renal stone disease: a commentary on the nature and significance of Randall's plaque.

Authors:  A P Evan; R J Unwin; J C Williams
Journal:  Nephron Physiol       Date:  2011-09-21

3.  ApaL1 urokinase and Taq1 vitamin D receptor gene polymorphisms in first-stone formers, recurrent stone formers, and controls in a Caucasian population.

Authors:  Serdar Aykan; Murat Tuken; Sezgin Gunes; Yigit Akin; Murat Ozturk; Serkan Seyhan; Emrah Yuruk; Mustafa Zafer Temiz; Ali Faik Yılmaz; Daniel P Nguyen
Journal:  Urolithiasis       Date:  2015-08-15       Impact factor: 3.436

Review 4.  Cystinuria: mechanisms and management.

Authors:  Donna J Claes; Elizabeth Jackson
Journal:  Pediatr Nephrol       Date:  2012-01-27       Impact factor: 3.714

Review 5.  The role of calcium phosphate in the development of Randall's plaques.

Authors:  Hans-Göran Tiselius
Journal:  Urolithiasis       Date:  2013-08-21       Impact factor: 3.436

6.  Hyperoxaluria-induced tubular ischemia: the effects of verapamil on the antioxidant capacity of the affected kidneys.

Authors:  Kemal Sarica; Alper Kafkasli; Fehmi Narter; Oguz Ozturk; Ozgur Yazici; Bilal Hamarat; Cahit Sahin; Bilal Eryildirim
Journal:  Urolithiasis       Date:  2016-06-09       Impact factor: 3.436

7.  Incorporation of osteopontin peptide into kidney stone-related calcium oxalate monohydrate crystals: a quantitative study.

Authors:  Jared S Gleberzon; Yinyin Liao; Silvia Mittler; Harvey A Goldberg; Bernd Grohe
Journal:  Urolithiasis       Date:  2018-12-19       Impact factor: 3.436

8.  Introduction of a Renal Papillary Grading System for Patients with Nephrolithiasis.

Authors:  Michael Seth Borofsky; Jessica E Paonessa; Andrew P Evan; James C Williams; Fredric L Coe; Elaine M Worcester; James E Lingeman
Journal:  J Endourol B Videourol       Date:  2015-12-03

9.  Microstructures of Randall's plaques and their interfaces with calcium oxalate monohydrate kidney stones reflect underlying mineral precipitation mechanisms.

Authors:  Ingo Sethmann; Gunnar Wendt-Nordahl; Thomas Knoll; Frieder Enzmann; Ludwig Simon; Hans-Joachim Kleebe
Journal:  Urolithiasis       Date:  2016-10-01       Impact factor: 3.436

Review 10.  How should patients with cystine stone disease be evaluated and treated in the twenty-first century?

Authors:  Kim Hovgaard Andreassen; Katja Venborg Pedersen; Susanne Sloth Osther; Helene Ulrik Jung; Søren Kissow Lildal; Palle Joern Sloth Osther
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.